Invesco’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $67.3M | Buy |
3,749,367
+263,764
| +8% | +$3.69M | 0.01% | 1028 |
|
|
2026
Q1 | $32.8M | Sell |
3,485,603
-37,236
| -1% | -$409K | ﹤0.01% | 1235 |
|
|
2025
Q4 | $43.8M | Buy |
3,522,839
+31,931
| +0.9% | +$425K | ﹤0.01% | 1134 |
|
|
2025
Q3 | $50M | Sell |
3,490,908
-46,299
| -1% | -$634K | 0.01% | 1092 |
|
|
2025
Q2 | $43.4M | Buy |
3,537,207
+106,577
| +3% | +$1.55M | 0.01% | 1106 |
|
|
2025
Q1 | $75.4M | Buy |
3,430,630
+1,364,345
| +66% | +$32.1M | 0.01% | 883 |
|
|
2024
Q4 | $46.9M | Sell |
2,066,285
-4,772
| -0.2% | -$104K | 0.01% | 1068 |
|
|
2024
Q3 | $37.6M | Buy |
2,071,057
+43,430
| +2% | +$1.01M | 0.01% | 1160 |
|
|
2024
Q2 | $59.1M | Buy |
2,027,627
+1,625,373
| +404% | +$48.2M | 0.01% | 941 |
|
|
2024
Q1 | $14.3M | Buy |
402,254
+236,375
| +142% | +$9.45M | ﹤0.01% | 1620 |
|
|
2023
Q4 | $7.22M | Buy |
165,879
+1,954
| +1% | +$76.9K | ﹤0.01% | 2031 |
|
|
2023
Q3 | $6.26M | Sell |
163,925
-11,703
| -7% | -$492K | ﹤0.01% | 2086 |
|
|
2023
Q2 | $7.22M | Buy |
175,628
+2,459
| +1% | +$118K | ﹤0.01% | 2036 |
|
|
2023
Q1 | $9.94M | Sell |
173,169
-40,489
| -19% | -$2.28M | ﹤0.01% | 1800 |
|
|
2022
Q4 | $12M | Buy |
213,658
+44,570
| +26% | +$2.27M | ﹤0.01% | 1726 |
|
|
2022
Q3 | $7.16M | Sell |
169,088
-12,527
| -7% | -$642K | ﹤0.01% | 2005 |
|
|
2022
Q2 | $9.81M | Buy |
181,615
+20,667
| +13% | +$1.24M | ﹤0.01% | 1866 |
|
|
2022
Q1 | $10.3M | Buy |
160,948
+5,623
| +4% | +$370K | ﹤0.01% | 1942 |
|
|
2021
Q4 | $10.4M | Sell |
155,325
-5,090
| -3% | -$344K | ﹤0.01% | 1989 |
|
|
2021
Q3 | $11M | Buy |
160,415
+7,493
| +5% | +$529K | ﹤0.01% | 1948 |
|
|
2021
Q2 | $10.4M | Sell |
152,922
-253,173
| -62% | -$17.9M | ﹤0.01% | 2034 |
|
|
2021
Q1 | $28.1M | Sell |
406,095
-100,122
| -20% | -$6.78M | 0.01% | 1344 |
|
|
2020
Q4 | $32.9M | Sell |
506,217
-82,136
| -14% | -$4.42M | 0.01% | 1190 |
|
|
2020
Q3 | $27.8M | Sell |
588,353
-50,159
| -8% | -$2.39M | 0.01% | 1157 |
|
|
2020
Q2 | $30M | Buy |
638,512
+505,986
| +382% | +$24.9M | 0.01% | 1119 |
|
|
2020
Q1 | $5.92M | Buy |
132,526
+37,731
| +40% | +$1.98M | ﹤0.01% | 1785 |
|
|
2019
Q4 | $5.53M | Sell |
94,795
-1,090,058
| -92% | -$64.9M | ﹤0.01% | 2110 |
|
|
2019
Q3 | $71.2M | Sell |
1,184,853
-39,741
| -3% | -$2.37M | 0.02% | 817 |
|
|
2019
Q2 | $68.4M | Buy |
1,224,594
+18,505
| +2% | +$953K | 0.02% | 863 |
|
|
2019
Q1 | $67.2M | Sell |
1,206,089
-2,650
| -0.2% | -$135K | 0.02% | 701 |
|
|
2018
Q4 | $54.5M | Buy |
1,208,739
+66,005
| +6% | +$3.62M | 0.02% | 729 |
|
|
2018
Q3 | $75.3M | Buy |
1,142,734
+10,273
| +0.9% | +$638K | 0.02% | 681 |
|
|
2018
Q2 | $72.9M | Sell |
1,132,461
-264,815
| -19% | -$16.4M | 0.02% | 672 |
|
|
2018
Q1 | $77.3M | Sell |
1,397,276
-75,657
| -5% | -$3.97M | 0.03% | 566 |
|
|
2017
Q4 | $70.5M | Sell |
1,472,933
-102,349
| -6% | -$5.01M | 0.03% | 611 |
|
|
2017
Q3 | $79.5M | Sell |
1,575,282
-28,480
| -2% | -$1.46M | 0.03% | 587 |
|
|
2017
Q2 | $87.4M | Buy |
1,603,762
+4,937
| +0.3% | +$236K | 0.03% | 554 |
|
|
2017
Q1 | $67.4M | Sell |
1,598,825
-1,409
| -0.1% | -$60.2K | 0.02% | 640 |
|
|
2016
Q4 | $68.6M | Buy |
1,600,234
+1,233,426
| +336% | +$50.1M | 0.02% | 650 |
|
|
2016
Q3 | $15.1M | Buy |
366,808
+43,744
| +14% | +$1.83M | 0.01% | 1262 |
|
|
2016
Q2 | $12.9M | Buy |
323,064
+116,842
| +57% | +$4.2M | ﹤0.01% | 1321 |
|
|
2016
Q1 | $6.95M | Sell |
206,222
-16,962
| -8% | -$528K | ﹤0.01% | 1621 |
|
|
2015
Q4 | $7.56M | Buy |
223,184
+14,784
| +7% | +$462K | ﹤0.01% | 1616 |
|
|
2015
Q3 | $6.21M | Sell |
208,400
-16,822
| -7% | -$526K | ﹤0.01% | 1713 |
|
|
2015
Q2 | $6.2M | Buy |
225,222
+22,109
| +11% | +$589K | ﹤0.01% | 1822 |
|
|
2015
Q1 | $5.12M | Buy |
203,113
+12,506
| +7% | +$296K | ﹤0.01% | 1960 |
|
|
2014
Q4 | $4.22M | Sell |
190,607
-1,762,199
| -90% | -$35.7M | ﹤0.01% | 2015 |
|
|
2014
Q3 | $39.6M | Buy |
1,952,806
+4,805
| +0.2% | +$95.6K | 0.02% | 907 |
|
|
2014
Q2 | $37.5M | Sell |
1,948,001
-17,150
| -0.9% | -$320K | 0.01% | 933 |
|
|
2014
Q1 | $36.9M | Buy |
1,965,151
+24,260
| +1% | +$468K | 0.02% | 924 |
|
|
2013
Q4 | $37.9M | Buy |
1,940,891
+27,593
| +1% | +$506K | 0.02% | 923 |
|
|
2013
Q3 | $31.5M | Buy |
1,913,298
+421,909
| +28% | +$6.77M | 0.01% | 973 |
|
|
2013
Q2 | $22.3M | Buy |
+1,491,389
| New | +$21.9M | 0.01% | 1058 |
|
Other funds holding IART
RCMNY
PCMI
Invesco's IART Position: Q2 2026 in Review
Invesco increased its Integra LifeSciences (IART) stake by 7.6% in Q2 2026, buying an estimated $3.69M and bringing the position to 3,749,367 shares worth $67.3M. The position accounts for 0.01% of the portfolio, ranked #1028.
Invesco first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $87.4M in Q2 2017. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- Invesco held 3,749,367 shares of Integra LifeSciences worth $67.3M as of Q2 2026.
- Invesco bought 263,764 Integra LifeSciences shares in Q2 2026, an estimated $3.69M.
- Integra LifeSciences made up 0.01% of Invesco's portfolio in Q2 2026, its #1028 holding.
- Invesco first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
- Invesco's Integra LifeSciences position peaked at $87.4M in Q2 2017.
- 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.